Literature DB >> 12850375

Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.

Rosario Gil-Benso1, Concha López-Ginés, Carmen Carda, José Antonio López-Guerrero, Jaime Ferrer, Antonio Pellín-Pérez, Antonio Llombart-Bosch.   

Abstract

Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Histologically, it is subdivided histologically into two main subtypes: alveolar (ARMS) and embryonal (ERMS). ARMS is characterized by t(2;13)(q35;q14) or its variant t(1;13)(p36;q14), which fuse PAX3 and PAX7, respectively, with FKHR to produce chimeric genes. ERMS is frequently associated with loss of heterozygosity of 11p15.5. We investigated seven RMS (three ARMS and four ERMS) by means of cytogenetic, fluorescence in situ hybridization, and molecular analyses, including the study of the main genes implicated in the G1- to S-phase cell cycle transition, and correlated these studies with pathologic findings and clinical outcome. All tumors showed clonal, numerical, and structural chromosomal abnormalities. Two ARMS had the t(2;13)(q35;q14) and the third a PAX7/FKHR fusion, a cryptic t(1;13)(p36;q14), undetected by cytogenetic techniques, but revealed by reverse transcriptase polymerase chain reaction. One ERMS showed a der(11)t(3;11)(p21;p15) as a sole structural anomaly. Gene amplification was seen in four tumors, as double minutes or in the form of homogeneously staining regions. Overexpression of MYCN oncogene was found in two ARMS; N-myc DNA probe detected oncogene amplification located on the double minutes of these cases. Analysis of the regulatory genes responsible for G1- to S-phase transition showed a homozygous deletion of the 9p21 locus genes in a spindle-cell ERMS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850375     DOI: 10.1016/s0165-4608(03)00026-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

Review 1.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

Review 2.  Developmental origins of fusion-negative rhabdomyosarcomas.

Authors:  Ken Kikuchi; Brian P Rubin; Charles Keller
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

3.  Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.

Authors:  Teresa San-Miguel; Sandra Pinto; Lara Navarro; Robert C Callaghan; Carlos Monteagudo; Concha López-Ginés; Miguel Cerdá-Nicolás; Rosario Gil-Benso
Journal:  Pathol Oncol Res       Date:  2015-06-03       Impact factor: 3.201

4.  Biphenotypic Sinonasal Sarcoma-Case Report and Review of Clinicopathological Features and Diagnostic Modalities.

Authors:  Chandala Chitguppi; Ian Koszewski; Kaitlin Collura; Mark Curtis; Gurston Nyquist; Mindy Rabinowitz; Marc Rosen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-16

5.  Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects.

Authors:  Jacob M Loupe; Patrick J Miller; Benjamin P Bonner; Elaine C Maggi; Jyothi Vijayaraghavan; Jovanny Zabaleta; Christopher M Taylor; Fern Tsien; Judy S Crabtree; Andrew D Hollenbach
Journal:  Oncotarget       Date:  2016-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.